$BRVO
Bravo Multinational Inc.

2021 Q1 Form 10-Q Financial Statement

#000109181821000053 Filed on April 26, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $145.6K $60.11M
YoY Change -99.76% 99666.66%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $145.6K $60.11M
YoY Change -99.76% 99567.39%
Operating Profit -$145.6K -$60.11M
YoY Change -99.76%
Interest Expense $87.00 $87.00
YoY Change 0.0%
% of Operating Profit
Other Income/Expense, Net -$87.00 $8.708K
YoY Change -101.0%
Pretax Income -$145.7K -$60.10M
YoY Change -99.76% 99552.95%
Income Tax
% Of Pretax Income
Net Earnings -$145.7K -$60.10M
YoY Change -99.76% 99552.95%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$3.058K -$4.800M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.150K $6.290K
YoY Change -2.23%
Cash & Equivalents $6.153K $6.286K
Short-Term Investments
Other Short-Term Assets $120.00 $0.00
YoY Change
Inventory
Prepaid Expenses $120.00
Receivables $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $6.273K $6.290K
YoY Change -0.27%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $6.273K $6.290K
Total Long-Term Assets $0.00 $0.00
Total Assets $6.273K $6.290K
YoY Change -0.27% 4738.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $110.0K $102.0K
YoY Change 7.85% -5.25%
Accrued Expenses $706.2K $345.2K
YoY Change 104.59% 29.76%
Deferred Revenue
YoY Change
Short-Term Debt $123.6K $13.99K
YoY Change 783.77% -0.29%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $971.3K $566.5K
YoY Change 71.45% -72.79%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $971.3K $566.5K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $971.3K $566.5K
YoY Change 71.45% -72.79%
SHAREHOLDERS EQUITY
Retained Earnings -$90.14M
YoY Change
Common Stock $89.17M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$965.1K -$560.2K
YoY Change
Total Liabilities & Shareholders Equity $6.273K $6.290K
YoY Change -0.27% 4738.46%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$145.7K -$60.10M
YoY Change -99.76% 99552.95%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities -$21.56K -$17.75K
YoY Change 21.48% -66.24%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $21.44K $17.75K
YoY Change 20.8% -66.21%
NET CHANGE
Cash From Operating Activities -$21.56K -$17.75K
Cash From Investing Activities
Cash From Financing Activities $21.44K $17.75K
Net Change In Cash -$120.00 $0.00
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$21.56K -$17.75K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001444839
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2020Q4 us-gaap Assets
Assets
6273 USD
CY2021Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
USD
CY2020Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
12000000 USD
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
24233 USD
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
26459 USD
CY2021Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
118750 USD
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
48079167 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
145594 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
60109405 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-145594 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-60109405 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
87 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
87 USD
CY2021Q1 BRVO Gain On Stock Payable Conversion
GainOnStockPayableConversion
USD
CY2020Q1 BRVO Gain On Stock Payable Conversion
GainOnStockPayableConversion
8795 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-87 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8708 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-145681 USD
CY2021Q1 dei City Area Code
CityAreaCode
757
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
306-6090
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6153 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6273 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2021Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 USD
CY2020Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
2725 USD
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
9490 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
9490 USD
CY2021Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
706167 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
587417 USD
CY2021Q1 us-gaap Liabilities
Liabilities
971334 USD
CY2020Q4 us-gaap Liabilities
Liabilities
825653 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
000-53505
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
BRAVO MULTINATIONAL INCORPORATED
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-4068651
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd., Unit 230
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Security12b Title
Security12bTitle
Common stock Par Value $0.0001
CY2021Q1 dei Trading Symbol
TradingSymbol
BRVO
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NONE
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47641010 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4763 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
89168393 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
89168393 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89992536 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-965061 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-819380 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6273 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6273 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2611 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3779 USD
CY2021Q1 BRVO Gain On Stock Payable Conversion
GainOnStockPayableConversion
USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
4763 USD
CY2020Q1 BRVO Gain On Stock Payable Conversion
GainOnStockPayableConversion
8795 USD
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
USD
CY2021Q1 BRVO Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 USD
CY2020Q4 BRVO Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 USD
CY2021Q1 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
USD
CY2020Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
120 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
6273 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
6273 USD
CY2021Q1 us-gaap Assets
Assets
6273 USD
CY2021Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
105727 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
100232 USD
CY2021Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 USD
CY2020Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
35800 USD
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
114150 USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
92714 USD
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
47641010 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
47641010 shares
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90138217 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-145681 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-965061 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60100697 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-145681 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-60100697 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47641010 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12520419 shares
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.80
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-145681 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-60100697 USD
CY2021Q1 BRVO Preferred Stock Issued For Current Year Board Of Directors Fees
PreferredStockIssuedForCurrentYearBoardOfDirectorsFees
USD
CY2020Q1 BRVO Preferred Stock Issued For Current Year Board Of Directors Fees
PreferredStockIssuedForCurrentYearBoardOfDirectorsFees
48000000 USD
CY2021Q1 BRVO Preferred Stock Issued For Current Year Consulting Fees
PreferredStockIssuedForCurrentYearConsultingFees
USD
CY2020Q1 BRVO Preferred Stock Issued For Current Year Consulting Fees
PreferredStockIssuedForCurrentYearConsultingFees
12000000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
120 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5495 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2580 USD
CY2021Q1 BRVO Accrued Board Of Directors Fees
AccruedBoardOfDirectorsFees
118750 USD
CY2020Q1 BRVO Accrued Board Of Directors Fees
AccruedBoardOfDirectorsFees
79167 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21556 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17745 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
USD
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
21436 USD
CY2020Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
17745 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21436 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17745 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-120 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6273 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6286 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6153 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6286 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
USD
CY2021Q1 us-gaap Stock Issued1
StockIssued1
USD
CY2020Q1 us-gaap Stock Issued1
StockIssued1
1593348 USD
CY2021Q1 BRVO Common Stock Exchanged For Due To Related Party
CommonStockExchangedForDueToRelatedParty
USD
CY2020Q1 BRVO Common Stock Exchanged For Due To Related Party
CommonStockExchangedForDueToRelatedParty
34562 USD
CY2021Q1 BRVO Preferred Stock Issued For Services
PreferredStockIssuedForServices
USD
CY2020Q1 BRVO Preferred Stock Issued For Services
PreferredStockIssuedForServices
60000000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-2087460 USD
CY2020Q1 BRVO Preferred Shares Issued For Services
PreferredSharesIssuedForServices
60000000 USD
CY2020Q1 BRVO Common Stock Issued To Pay Due To Related Party Value
CommonStockIssuedToPayDueToRelatedPartyValue
34562 USD
CY2020Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
1593348 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-60100697 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-560247 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-819380 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:left; margin-top:8pt; margin-bottom:0pt; "> <span style="font-weight:bold; ">Use of Estimates</span><span style="font-weight:bold; "/></p> <p style="font-family:Times New Roman, Times, serif; font-size:10pt; text-align:justify; margin-top:8pt; margin-bottom:0pt; ">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p>
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42312 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
42312 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
42312 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2021Q1 BRVO Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 USD
CY2020Q4 BRVO Notes Receivable Related Parties Current Gross
NotesReceivableRelatedPartiesCurrentGross
418000 USD
CY2021Q1 BRVO Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 USD
CY2020Q4 BRVO Allowance For Notes And Loans Receivable Related Party Current
AllowanceForNotesAndLoansReceivableRelatedPartyCurrent
418000 USD
CY2021Q1 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
USD
CY2020Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
USD
CY2021Q1 us-gaap Notes Payable
NotesPayable
9490 USD
CY2020Q4 us-gaap Notes Payable
NotesPayable
9490 USD
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
87 USD
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
87 USD
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
40000000 shares
CY2021Q1 us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
Preferred stock - A can be converted into 100 shares of common stock, have dividend rights at 100 times common and have voting rights equal to 100 shares of common stock.
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q1 BRVO Shares Authorized
SharesAuthorized
1050000000 shares
CY2017Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2020Q1 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
28580 USD
CY2020Q1 BRVO Loss On Loan Conversion
LossOnLoanConversion
5982 USD
CY2020Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
14778 USD
CY2021Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1:300
CY2020Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
0 USD
CY2021Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
0 USD

Files In Submission

Name View Source Status
0001091818-21-000053-index-headers.html Edgar Link pending
0001091818-21-000053-index.html Edgar Link pending
0001091818-21-000053.txt Edgar Link pending
0001091818-21-000053-xbrl.zip Edgar Link pending
brvo-20210331.xsd Edgar Link pending
brvo-20210331_cal.xml Edgar Link unprocessable
brvo-20210331_def.xml Edgar Link unprocessable
brvo-20210331_lab.xml Edgar Link unprocessable
brvo-20210331_pre.xml Edgar Link unprocessable
brvo10q2021.htm Edgar Link pending
brvo10q2021_htm.xml Edgar Link completed
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending